PALONPRI Trademark

Trademark Overview

On Tuesday, September 23, 2014, a trademark application was filed for PALONPRI with the United States Patent and Trademark Office. The USPTO has given the PALONPRI trademark a serial number of 86403227. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 6, 2023. This trademark is owned by AstraZeneca AB. The PALONPRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
palonpri

General Information

Serial Number86403227
Word MarkPALONPRI
Filing DateTuesday, September 23, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 6, 2023
Registration Number4980659
Registration DateTuesday, June 21, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 18, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, January 6, 2023CANCELLED SEC. 8 (6-YR)
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 21, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 21, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, April 5, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, March 1, 2016NOTICE OF ALLOWANCE CANCELLED
Sunday, April 3, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 1, 2016TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, October 13, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 18, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 18, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 29, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 16, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 16, 2015ASSIGNED TO LIE
Wednesday, July 1, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 30, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 29, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 29, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 16, 2015NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, January 16, 2015PRIORITY ACTION E-MAILED
Friday, January 16, 2015PRIORITY ACTION WRITTEN
Friday, January 16, 2015NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, January 16, 2015PRIORITY ACTION E-MAILED
Friday, January 16, 2015PRIORITY ACTION WRITTEN
Monday, January 12, 2015ASSIGNED TO EXAMINER
Wednesday, October 1, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 26, 2014NEW APPLICATION ENTERED

Related Keywords

palonpri diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal